Clinical Trial Update: Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating donor mesenchymal stem cells for the management and reconstruction of nonunion fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonunion Fracture

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Indonesia University | Conditions: Healing of Fracture | Phase 1 | Status: UNKNOWN